Please ensure Javascript is enabled for purposes of website accessibility

Deal Gets Clean Bill of Health

By Tom Taulli – Updated Nov 16, 2016 at 4:45PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Will Pacificare's deal with American Medical Security prove to be a lucrative link?

Mergers and acquisitions can be risky -- and, in many cases, downright disastrous. But in the managed health-care industry, deal-making has become a necessity for growth. An example is WellPoint (NYSE:WLP), which has become a health-care powerhouse. But the transactions can be complex and political, as seen with the company's recent combination with Anthem (NYSE:ATH).

Yesterday, we saw the latest deal in the sector: Pacificare's (NYSE:PHS) purchase of American Medical Security Group (NYSE:AMZ). The price tag comes to roughly $500 million. No doubt, American Medical shareholders were happy; the stock price surged 37% to $31.91.

Interestingly enough, Pacificare's stock price increased by 5.5% to $36.32. Then again, there is a lot to like about the deal.

American Medical will remain as a wholly owned subsidiary and maintain its headquarters in Green Bay, Wis. It's really "business as usual," and thus there should be few integration problems.

Pacificare will obtain access to the extensive distribution network of America Medical, which includes more than 32,000 independent agents. It will also position Pacificare in a major growth area for its industry; that is, individual and small group customer segments. To this end, American Medical will bring new proprietary products for these customer segments.

The transaction is expected to be accretive to earnings in 2005. As a result, Pacificare raised its 2005 net income guidance to $360 million to $375 million, which is up from $350 million to $360 million.

Over the past few years, Pacificare has been gearing up its acquisition's growth strategy. And, if this deal is any indication, the company is off to a good start.

Fool contributor Tom Taulli owns none of the shares mentioned in the article.

None

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Elevance Health Inc. Stock Quote
Elevance Health Inc.
ELV
$448.14 (-1.26%) $-5.71

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.